Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?


OverviewForecastFinancialsChart

Eledon Pharmaceuticals Ownership Summary


Eledon Pharmaceuticals is owned by 21.55% institutional investors, 1.09% insiders, and 77.36% retail investors. Bvf inc/il is the largest institutional shareholder, holding 8.34% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.05% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEledon Pharmaceuticals21.55%1.09%77.36%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il6.29M8.34%$19.38M
Blackrock funding, inc. /de4.38M5.81%$13.50M
Vanguard group4.04M5.24%$6.10M
Ra capital management3.57M4.62%$9.24M
Ensign peak advisors2.46M3.27%$7.59M
Zimmer partners, lp1.88M2.49%$5.78M
Geode capital management1.79M2.38%$5.52M
Sphera funds management1.77M2.35%$5.46M
Catalio capital management, lp1.64M2.17%$5.05M
Blue owl capital lp1.42M1.88%$4.37M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management650.00K1.67%$2.00M
22nw, lp636.36K1.34%$1.96M
Blue owl capital lp1.42M1.18%$4.37M
Catalio capital management, lp1.64M1.06%$5.05M
Sphera funds management1.77M0.87%$5.46M
Sanofi814.98K0.75%$2.51M
Bvf inc/il6.29M0.62%$19.38M
Awm investment company1.10M0.38%$3.39M
Kingdon capital management1.04M0.35%$3.20M
Exome asset management114.14K0.34%$386.95K

Top Buyers

HolderShares% AssetsChange
Wellington management group llp1.28M0.00%1.28M
Vanguard group4.04M0.00%771.90K
Blackrock funding, inc. /de4.38M0.00%755.04K
Kovitz investment group partners732.98K0.01%732.98K
Vanguard fiduciary trust503.76K0.00%503.76K

Top Sellers

HolderShares% AssetsChange
First light asset management---2.60M
Armistice capital---2.36M
Siren---2.07M
Frazier life sciences management---1.18M
Nantahala capital management---1.14M

New Positions

HolderShares% AssetsChangeValue
Kovitz investment group partners732.98K0.01%732.98K$1.90M
Vanguard fiduciary trust503.76K0.00%503.76K$1.55M
Inspire investing194.69K0.09%194.69K$802.12K
Bit capital gmbh134.00K0.02%134.00K$412.72K
Cambridge investment research advisors48.20K0.00%48.20K$148.00K

Sold Out

HolderChange
Ifs advisors-100.00
Ameritas advisory services-1.00K
Citadel advisors-1.40K
Amalgamated bank-1.76K
Point72 (difc)-1.78K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202673-24.74%16,252,212-63.19%210.66%47-25.40%9-50.00%
Dec 31, 202555-36.78%23,315,065-36.07%301.35%33-28.26%11-45.00%
Sep 30, 2025876.10%36,469,788-9.28%471.74%46-2042.86%
Jun 30, 2025882.33%40,843,2136.23%522.13%4837.14%16-23.81%
Mar 31, 202514-81.82%17,746,490-53.88%290.54%4-93.75%4100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.36M3.05%-
iShares Russell 2000 ETF1.79M2.32%42.59K
Vanguard US Total Market Shares ETF1.15M1.92%-
Vanguard Institutional Extnd Mkt Idx Tr857.64K1.11%-
iShares Russell 2000 Value ETF592.61K0.77%3.19K
Fidelity Small Cap Index546.70K0.72%-2.22K
Fidelity Extended Market Index412.63K0.53%35.91K
MEDICAL BioHealth EUR Acc294.49K0.49%-
Vanguard Russell 2000 ETF377.07K0.49%7.87K
Russell 2000 Equity Index Fund B358.06K0.47%-178.00

Recent Insider Transactions


DateNameRoleActivityValue
Oct 29, 2024BVF PARTNERS L P/IL-Buy$440.49
Oct 29, 2024BVF PARTNERS L P/IL-Buy$2.10K
Oct 29, 2024BVF PARTNERS L P/IL-Buy$2.21K
May 09, 2024BVF PARTNERS L P/IL-Buy$1.95M
May 09, 2024BVF PARTNERS L P/IL-Buy$232.07

Insider Transactions Trends


DateBuySell
2035 Q1--
2025 Q1--
2024 Q43-
2024 Q26-
2023 Q4--

ELDN Ownership FAQ


Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 21.55%, followed by 1.09% insiders and 77.36% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Eledon Pharmaceuticals falls below.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 8.34%), Blackrock funding, inc. /de (4.38M shares, 5.81%), and Vanguard group (4.04M shares, 5.24%). Together, they hold 19.39% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cm management is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.67% of its assets in 650K Eledon Pharmaceuticals shares, valued at 2M$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.05% of its total shares outstanding invested in 2.36M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools